Skip to main content
NIH funding notice RFA-MH-21-145

HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)

Closed on March 18, 2021.

Posted
January 11, 2021
Close date
March 18, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,155,199 in first-year total cost, median $3,155,199.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-G (08)]1

Most frequent institutions

  1. UNIV OF MASSACHUSETTS MED SCH WORCESTER1
Competing awards under RFA-MH-21-145 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Supporting Treatment Access and Recovery for Co-Occurring Opioid Use and Mental Health Disorders (STAR-COD)1R01MH128904-01GONZALEZ, GERARDOLI, WENJUNOLMSTEAD, TODD ALDENSMELSON, DAVID AUNIV OF MASSACHUSETTS MED SCH WORCESTER, MA$3,155,199ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.